個股熱度排行 | 2月22日港股盤前
根據uSMART輿情監測數據，從21日晚間到22日港股盤前時間段，市場關注指數最高的5只股票是騰訊控股、快手-W、海底撈、綠葉製藥、先聲藥業。
2月22日—港股關注排行TOP5
騰訊控股
關注度第一爲騰訊控股，該股上個交易日收盤下跌5.23%，報於445.40港元。近5個交易日累計下跌5.64%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
“東數西算”推動西部地區數字化進程 騰訊、字節等巨頭加碼佈局
奈飛還能漲54%？機構看好其快速增長 招商證券維持騰訊“強推”評級
快手-W
關注度第二爲快手-W，該股上個交易日收盤下跌7.29%，報於87.15港元。近5個交易日累計下跌2.90%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
快手澄清指斥25億人幣購買雙奧版權屬假消息
快手簽下歐冠版權，“25億購買雙奧版權”爲假消息
海底撈
關注度第三爲海底撈，該股上個交易日收盤下跌5.54%，報於19.08港元。近5個交易日累計下跌5.07%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
海底撈不“香”了？營收大增卻預虧至少38億，近一年市值蒸發3600億港元！
安能物流獲納入恆生綜合指數成份股 海底撈預計2021年收入增逾40%
綠葉製藥
關注度第四爲綠葉製藥，該股上個交易日收盤上漲0.58%，報於3.44港元。近5個交易日累計上漲1.18%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
綠葉製藥簽訂抗腫瘤創新藥內地市場推廣協議
綠葉製藥與華昊中天就抗腫瘤創新藥優替德隆注射液在中國大陸市場推廣達成合作
先聲藥業
關注度第五爲先聲藥業，該股上個交易日收盤下跌0.33%，報於9.11港元。近5個交易日累計上漲8.45%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
先聲藥業期年度純利預增約121%-130%；保利協鑫能源擬更名爲"協鑫科技控股"
先聲藥業預期2021年股東應佔利潤同比增長121%至130%
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
